title: Voltage-gated potassium channel Kv1.3 blocker as a potential treatment for rat anti-glomerular basement membrane glomerulonephritis.
abstract: The voltage-gated potassium channel Kv1.3 has been recently identified as a molecular target that allows the selective pharmacological suppression of effector memory T cells (T(EM)) without affecting the function of naïve T cells (T(N)) and central memory T cells (T(CM)). We found that Kv1.3 was expressed on glomeruli and some tubules in rats with anti-glomerular basement membrane glomerulonephritis (anti-GBM GN). A flow cytometry analysis using kidney cells revealed that most of the CD4(+) T cells and some of the CD8(+) T cells had the T(EM) phenotype (CD45RC(-)CD62L(-)). Double immunofluorescence staining using mononuclear cell suspensions isolated from anti-GBM GN kidney showed that Kv1.3 was expressed on T cells and some macrophages. We therefore investigated whether the Kv1.3 blocker Psora-4 can be used to treat anti-GBM GN. Rats that had been given an injection of rabbit anti-rat GBM antibody were also injected with Psora-4 or the vehicle intraperitoneally. Rats given Psora-4 showed less proteinuria and fewer crescentic glomeruli than rats given the vehicle. These results suggest that T(EM) and some macrophages expressing Kv1.3 channels play a critical role in the pathogenesis of crescentic GN and that Psora-4 will be useful for the treatment of rapidly progressive glomerulonephritis.
authors.affiliation: Dept. of Nephrology, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan. dr20015@ndmc.ac.jp
authors.forename: Toshitake
authors.initials: T
authors.lastname: Hyodo
authors.forename: Takashi
authors.initials: T
authors.lastname: Oda
authors.forename: Yuichi
authors.initials: Y
authors.lastname: Kikuchi
authors.forename: Keishi
authors.initials: K
authors.lastname: Higashi
authors.forename: Taketoshi
authors.initials: T
authors.lastname: Kushiyama
authors.forename: Kojiro
authors.initials: K
authors.lastname: Yamamoto
authors.forename: Muneharu
authors.initials: M
authors.lastname: Yamada
authors.forename: Shigenobu
authors.initials: S
authors.lastname: Suzuki
authors.forename: Ryota
authors.initials: R
authors.lastname: Hokari
authors.forename: Manabu
authors.initials: M
authors.lastname: Kinoshita
authors.forename: Shuhji
authors.initials: S
authors.lastname: Seki
authors.forename: Hidehiko
authors.initials: H
authors.lastname: Fujinaka
authors.forename: Tadashi
authors.initials: T
authors.lastname: Yamamoto
authors.forename: Soichiro
authors.initials: S
authors.lastname: Miura
authors.forename: Hiroo
authors.initials: H
authors.lastname: Kumagai
mesh_terms: D000818:Animals; D001323:Autoantibodies; D001485:Basement Membrane / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D016207:Cytokines / Q000096:biosynthesis; D005363:Ficusin / Q000627:therapeutic use*; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D007678:Kidney Glomerulus / Q000276:immunology*; D051664:Kv1.3 Potassium Channel / Q000037:antagonists & inhibitors* / Q000096:biosynthesis; D051381:Rats; D011921:Rats, Inbred WKY; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*
chemical_list: C499898:5-(4-phenylbutoxy)psoralen; D001323:Autoantibodies; D016207:Cytokines; D051664:Kv1.3 Potassium Channel; C051951:antiglomerular basement membrane antibody; D005363:Ficusin
references.citation: Kidney Int. 2009 Mar;75(5):526-35
references.pmid: 19092796
references.citation: J Am Soc Nephrol. 1999 Apr;10(4):752-9
references.pmid: 10203359
references.citation: Am J Physiol Gastrointest Liver Physiol. 2006 Aug;291(2):G267-74
references.pmid: 16574986
references.citation: Nephron. 2002 Aug;91(4):601-5
references.pmid: 12138261
references.citation: J Am Soc Nephrol. 2001 Dec;12(12):2636-2644
references.pmid: 11729232
references.citation: Ann N Y Acad Sci. 2007 Jun;1107:22-31
references.pmid: 17804529
references.citation: Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):11094-9
references.pmid: 16043714
references.citation: J Am Soc Nephrol. 1999 Mar;10(3):499-506
references.pmid: 10073600
references.citation: Allergol Int. 2008 Jun;57(2):115-20
references.pmid: 18427164
references.citation: Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17414-9
references.pmid: 17088564
references.citation: Ann Rheum Dis. 2010 Nov;69(11):2034-41
references.pmid: 20472588
references.citation: J Exp Med. 1978 Feb 1;147(2):369-84
references.pmid: 146726
references.citation: J Immunol. 1997 Jun 1;158(11):5484-91
references.pmid: 9164971
references.citation: J Immunol. 1999 Aug 15;163(4):2243-8
references.pmid: 10438967
references.citation: Am J Physiol Cell Physiol. 2006 Feb;290(2):C345-51
references.pmid: 16403947
references.citation: Nephrol Dial Transplant. 2001;16 Suppl 5:3-7
references.pmid: 11509677
references.citation: J Clin Invest. 2003 Jun;111(11):1703-13
references.pmid: 12782673
references.citation: Mol Pharmacol. 2005 Apr;67(4):1369-81
references.pmid: 15665253
references.citation: J Immunol. 1997 May 15;158(10):4978-83
references.pmid: 9144517
references.citation: J Biol Chem. 2006 Dec 8;281(49):37675-85
references.pmid: 17038323
references.citation: J Am Soc Nephrol. 2006 May;17(5):1253-63
references.pmid: 16624930
references.citation: Adv Immunol. 2007;96:41-101
references.pmid: 17981204
references.citation: Diabetes. 2002 Jun;51(6):1745-53
references.pmid: 12031961
references.citation: J Immunol. 2001 Oct 1;167(7):3740-5
references.pmid: 11564790
references.citation: J Am Soc Nephrol. 1996 Nov;7(11):2271-8
references.pmid: 8959617
references.citation: Biochem Biophys Res Commun. 2010 May 28;396(2):304-9
references.pmid: 20403337
references.citation: Clin Exp Immunol. 1997 Jul;109(1):134-42
references.pmid: 9218836
references.citation: J Am Soc Nephrol. 2003 Apr;14(4):888-98
references.pmid: 12660323
references.citation: J Am Soc Nephrol. 2009 May;20(5):969-79
references.pmid: 19339380
references.citation: Gastroenterology. 2003 Feb;124(2):410-21
references.pmid: 12557147
references.citation: J Clin Invest. 1994 Jan;93(1):273-9
references.pmid: 7904269
references.citation: Arthritis Res Ther. 2008;10(4):R93
references.pmid: 18710567
references.citation: J Clin Invest. 1996 Jun 1;97(11):2525-33
references.pmid: 8647945
references.citation: Immunity. 2008 Oct 17;29(4):602-14
references.pmid: 18835197
references.citation: Transplant Proc. 2009 Jul-Aug;41(6):2601-6
references.pmid: 19715983
references.citation: Biochem Biophys Res Commun. 2007 Jan 26;352(4):913-8
references.pmid: 17157812
references.citation: Nat Immunol. 2003 Sep;4(9):835-42
references.pmid: 12942084
references.citation: Kidney Int. 1995 Dec;48(6):1738-46
references.pmid: 8587234
references.citation: J Immunol. 1989 May 1;142(9):3083-90
references.pmid: 2785133
references.citation: J Am Soc Nephrol. 1997 Jul;8(7):1174-8
references.pmid: 9219168
references.citation: J Immunol. 2001 Jun 1;166(11):6578-84
references.pmid: 11359810
references.citation: Kidney Int. 2008 Nov;74(10):1294-309
references.pmid: 18974760
references.citation: Mol Pharmacol. 2004 Jun;65(6):1364-74
references.pmid: 15155830
references.citation: J Immunol. 2001 Jan 15;166(2):1009-15
references.pmid: 11145680
references.citation: J Cell Physiol. 2004 May;199(2):194-9
references.pmid: 15040001
references.citation: J Biol Chem. 2003 Nov 21;278(47):46307-20
references.pmid: 12923194
references.citation: Cell. 2009 Aug 7;138(3):606.e1-2
references.pmid: 19665979
references.citation: Expert Opin Investig Drugs. 2006 Oct;15(10):1167-77
references.pmid: 16989594
references.citation: J Immunol. 2008 Jun 15;180(12):7948-57
references.pmid: 18523258
references.citation: Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13942-7
references.pmid: 11717451
references.citation: Mol Pharmacol. 2006 Oct;70(4):1204-11
references.pmid: 16835355
references.citation: J Invest Dermatol. 2007 Jun;127(6):1419-29
references.pmid: 17273162
references.citation: J Clin Invest. 1981 Sep;68(3):686-98
references.pmid: 7276168
references.citation: Nephrol Dial Transplant. 2003 Mar;18(3):607-9
references.pmid: 12584287
references.citation: Trends Pharmacol Sci. 2004 May;25(5):280-9
references.pmid: 15120495
references.citation: Adv Exp Med Biol. 2010;661:405-17
references.pmid: 20204745
references.citation: Arch Dermatol Res. 2000 Oct;292(10):519-21
references.pmid: 11142774
references.citation: J Immunol. 1998 Apr 15;160(8):3713-8
references.pmid: 9558072
references.citation: Curr Opin Biotechnol. 1997 Dec;8(6):749-56
references.pmid: 9425667
references.citation: Pharmacol Rev. 2003 Dec;55(4):583-6
references.pmid: 14657415
references.citation: Arthritis Rheum. 2009 Sep;60(9):2830-8
references.pmid: 19714581
references.citation: Exp Biol Med (Maywood). 2007 Nov;232(10):1338-54
references.pmid: 17959847